Mitsutaka Kitano

892 citations

23 papers · 608 indexed · h-index 12

Co-authors: Akihiko Sato Ryu Yoshida Takao Shishido Akira Naito Takeshi Noshi Atsuko Yamamoto Makoto Kawai Masanori Kobayashi
Topics: Influenza Virus Research Studies (18 papers)Respiratory viral infections research (15 papers)Immune Cell Function and Interaction (5 papers)
Cited by: Epidemiology Infectious Diseases Immunology
Journals: PLoS ONE Scientific Reports Antimicrobial Agents and Chemotherapy
Partner nations: Japan United States Thailand

In The Last Decade

Mitsutaka Kitano

23 papers receiving 594 citations

Peers

Countries citing papers authored by Mitsutaka Kitano

Since Specialization

Citations

This map shows the geographic impact of Mitsutaka Kitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsutaka Kitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsutaka Kitano more than expected).

Fields of papers citing papers by Mitsutaka Kitano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsutaka Kitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsutaka Kitano. The network helps show where Mitsutaka Kitano may publish in the future.

Co-authorship network of co-authors of Mitsutaka Kitano

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsutaka Kitano. A scholar is included among the top collaborators of Mitsutaka Kitano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsutaka Kitano. Mitsutaka Kitano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets 2020 ·Influenza and Other Respiratory Viruses ·Mitsutaka Kitano,Takanobu Matsuzaki,(unknown),(unknown),Takahiro Noda,Yuki Yoshida,Kenji Sato,(unknown),Tohru Mizutare,Ryu Yoshida,Akihiko Sato,Hiroshi Kamimori,Takao Shishido,Akira Naito	8
2	Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection 2020 ·Journal of Antimicrobial Chemotherapy ·(unknown),Takeshi Noshi,Kenji Sato,Tôru Ishibashi,Yuki Yoshida,(unknown),Motoyasu Onishi,Mitsutaka Kitano,(unknown),Makoto Kawai,Ryu Yoshida,Akihiko Sato,Takao Shishido,Akira Naito	15
3	Antibody dynamics in Japanese paediatric patients with influenza A infection treated with neuraminidase inhibitors in a randomised trial 2019 ·Scientific Reports ·Nobuo Hirotsu,Yutaka Saisho,(unknown),Mitsutaka Kitano,Takao Shishido	2
4	Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models 2019 ·PLoS ONE ·Keita Fukao,(unknown),Takeshi Noshi,Mitsutaka Kitano,Takahiro Noda,Makoto Kawai,Ryu Yoshida,Akihiko Sato,Takao Shishido,Akira Naito	39
5	In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit 2018 ·Antiviral Research ·Takeshi Noshi,Mitsutaka Kitano,K. Taniguchi,Atsuko Yamamoto,Shinya Omoto,Keiko Baba,Takashi Hashimoto,(unknown),(unknown),Kazunari Hattori,Makoto Kawai,Ryu Yoshida,Masanori Kobayashi,Tomokazu Yoshinaga,Akihiko Sato,Masatoshi Okamatsu,Yoshihiro Sakoda,Hiroshi Kida,Takao Shishido,Akira Naito	267
6	1350. Therapeutic Effects of Baloxavir Marboxil against Influenza A Virus Infection in Ferrets 2018 ·Open Forum Infectious Diseases ·Mitsutaka Kitano,Takanobu Matsuzaki,(unknown),(unknown),Takahiro Noda,Yuki Yoshida,Kenji Sato,Ryu Yoshida,Akihiko Sato,Hiroshi Kamimori,Takao Shishido,(unknown)	2
7	Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection 2018 ·Journal of Antimicrobial Chemotherapy ·Keita Fukao,Takeshi Noshi,Atsuko Yamamoto,Mitsutaka Kitano,Yukio Ando,Takahiro Noda,(unknown),(unknown),Naoko Higuchi,Minoru Ikeda,Takao Shishido,Akira Naito	74
8	Synergistic Antiviral Activity of S-033188/S-033447, a Novel Inhibitor of Influenza Virus Cap-Dependent Endonuclease, in Combination with Neuraminidase Inhibitors In Vitro 2017 ·Open Forum Infectious Diseases ·Mitsutaka Kitano,Atsuko Yamamoto,Takeshi Noshi,Makoto Kawai,Ryu Yoshida,Akihiko Sato,Takao Shishido,Akira Naito	11
9	Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae 2015 ·Antiviral Research ·Motoyasu Onishi,Mitsutaka Kitano,K. Taniguchi,Tomoyuki Homma,Masanori Kobayashi,Tomokazu Yoshinaga,Akira Naito,Akihiko Sato	7
10	The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice 2014 ·Antiviral Research ·Makoto Kodama,Ryu Yoshida,(unknown),(unknown),Mitsutaka Kitano,(unknown),Takeshi Noshi,Takahiro Seki,Ken‐ichi Okazaki,Masakatsu Tsuji,Takushi Kanazu,Hiroshi Kamimori,Tomoyuki Homma,Masanori Kobayashi,Yoshihiro Sakoda,Hiroshi Kida,Akihiko Sato,Yoshinori Yamano	6
11	Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets 2014 ·Vaccine ·Motoyasu Onishi,Mitsutaka Kitano,K. Taniguchi,Tomoyuki Homma,Masanori Kobayashi,Akihiko Sato,Cevayir Coban,Ken J. Ishii	8
12	The Effect of Intravenous Peramivir, Compared with Oral Oseltamivir, on the Outcome of Post-Influenza Pneumococcal Pneumonia in Mice 2014 ·Antiviral Therapy ·(unknown),Shigeki Nakamura,Masafumi Seki,Naoki Iwanaga,Toshiki Kajihara,Mitsutaka Kitano,Tomoyuki Homma,Shintaro Kurihara,Yoshifumi Imamura,Taiga Miyazaki,Koichi Izumikawa,Hiroshi Kakeya,Katsunori Yanagihara,Shigeru Kohno	16
13	Pathogenicity of Pandemic H1N1 Influenza A Virus in Immunocompromised Cynomolgus Macaques 2013 ·PLoS ONE ·(unknown),Misako Nakayama,Yasushi Itoh,Hirohito Ishigaki,Mitsutaka Kitano,(unknown),Hideaki Ishida,(unknown),Shintaro Shichinohe,Masatoshi Okamatsu,Yoshihiro Sakoda,Hideaki Tsuchiya,Shinichiro Nakamura,Hiroshi Kida,Kazumasa Ogasawara	20
14	Protection against H5N1 Highly Pathogenic Avian and Pandemic (H1N1) 2009 Influenza Virus Infection in Cynomolgus Monkeys by an Inactivated H5N1 Whole Particle Vaccine 2013 ·PLoS ONE ·Misako Nakayama,Shintaro Shichinohe,Yasushi Itoh,Hirohito Ishigaki,Mitsutaka Kitano,(unknown),(unknown),Hideaki Ishida,(unknown),Masatoshi Okamatsu,Yoshihiro Sakoda,(unknown),Hideaki Tsuchiya,Shinichiro Nakamura,Quynh Mai Le,Mutsumi Ito,Yoshihiro Kawaoka,Hiroshi Kida,Kazumasa Ogasawara	23
15	Efficacy of Repeated Intravenous Injection of Peramivir against Influenza A (H1N1) 2009 Virus Infection in Immunosuppressed Mice 2013 ·Antimicrobial Agents and Chemotherapy ·Mitsutaka Kitano,Makoto Kodama,Yasushi Itoh,Takushi Kanazu,Masanori Kobayashi,Ryu Yoshida,Akihiko Sato	13
16	Establishment of a cynomolgus macaque model of influenza B virus infection 2010 ·Virology ·Mitsutaka Kitano,Yasushi Itoh,Makoto Kodama,Hirohito Ishigaki,Misako Nakayama,(unknown),Hideaki Ishida,Hideaki Tsuchiya,Ryuzo Torii,Keiko Baba,Ryu Yoshida,Akihiko Sato,Kazumasa Ogasawara	18
17	Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B5401-positive individuals 2009 ·Human Immunology* ·Masao Hashimoto,Mitsutaka Kitano,(unknown),Hirokazu Koizumi,(unknown),Shinichi Oka,Masafumi Takiguchi	2
18	Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B4801 2009 ·Human Immunology* ·Hayato Murakoshi,Mitsutaka Kitano,Tomohiro Akahoshi,Yuka Kawashima,(unknown),Shinichi Oka,Masafumi Takiguchi	5
19	Identification and characterization of HLA-B5401-restricted HIV-1-Nef and Pol-specific CTL epitopes 2008 ·Microbes and Infection* ·Mitsutaka Kitano,Naoki Kobayashi,Yuka Kawashima,Tomohiro Akahoshi,Kiyoshi Nokihara,Shinichi Oka,(unknown)	8
20	[Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia]. 1999 ·PubMed ·Y Toyonaga,(unknown),Mitsutaka Kitano,(unknown),(unknown),(unknown),R Ohno	1

About Mitsutaka Kitano

Mitsutaka Kitano is a scholar working on Virology, Immunology and Epidemiology, having authored 23 papers that have together received 608 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (18 papers), Respiratory viral infections research (15 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Epidemiology (472 citations), Infectious Diseases (182 citations) and Immunology (133 citations). Mitsutaka Kitano has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Akihiko Sato, Ryu Yoshida, Takao Shishido, Akira Naito, Takeshi Noshi, Atsuko Yamamoto, Makoto Kawai, Masanori Kobayashi, Yoshihiro Sakoda and Masatoshi Okamatsu. Their work appears in journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact